Who Is the Genomind Professional PGx Test For
The Genomind Professional PGx Test with the Neuropsych Pharmacogenetic Report is designed to provide clinically relevant genetic insights that may support informed therapy decisions in mental health and neurology. The test helps to better understand individual genetic predispositions and how the body may respond to different medications, supporting safer and more personalized treatment approaches.
Clinical Areas Where PGx Insights May Be Relevant
The Genomind Professional PGx Test with the Neuropsych Pharmacogenetic Report provides insights across multiple health areas, including:
Mental Health
- Depression
- Anxiety disorders
- Bipolar disorder
- Obsessive-Compulsive Disorder (OCD)
- Post-Traumatic Stress Disorder (PTSD)
Neurology & Chronic Pain- Migraine
- Neurological disorders
- Fibromyalgia
- Chronic pain conditions
When the Test May Be Considered
Clinicians may consider recommending the Genomind Professional PGx Test for adult patients who:
- Are starting pharmacological therapy
- Are changing or adjusting current medications
- Experience insufficient response or adverse effects during treatment
- Require additional genetic context to support medication selection or dosing decisions
Pharmacogenetic testing is intended to complement clinical assessment and professional judgment, not to replace them.
Age Considerations
Clinicians can recommend the Genomind Professional PGx Test with the Neuropsych Pharmacogenetic Report for patients from the age of 18.
Important Note: PGx Testing for Patients Under 18.
(While the Genomind Professional PGx Test is clinically available for patients starting from the age of 5, its use for minors (under 18 years of age) represents a specific therapeutic decision. Such testing requires careful clinical consideration and strict adherence to applicable ethical, medical, and legal standards, and must be determined solely at the discretion of the treating clinician).
Purpose of Pharmacogenetic Testing
Genomind Professional PGX test pharmacogenetic testing supports a more informed understanding of how genetic variability may influence medication response. By integrating genetic insights with clinical evaluation, clinicians can be better equipped to support wellness and therapy decisions based on each patient’s unique genetic profile.